Erny-Albrecht, K. and Erdmann, E. (2009) “Cost-effectiveness of pioglitazone in patients with type 2 diabetes and a history of macrovascular disease in a Swiss setting”, Swiss Medical Weekly, 139(1112), pp. 173–173. doi: 10.4414/smw.2009.12381.